People · Operator
Named in public records as an officer, director or promoter · active 2017–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CARISMA Therapeutics Inc. | — | Biotechnology | Series C | $95.0M | $1.3B | 2017 |
| AmbAgon Therapeutics Inc. | — | Biotechnology | Series C | $55.4M | $35.9M | 2020 |
| Nitrome Biosciences, Inc | — | Biotechnology | Series B | $18.9M | $680.1M | 2020 |
| Rodeo Therapeutics Corp | — | Biotechnology | Series A | $14.3M | $323.6M | 2018 |
Margarita Chavez at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Margarita Chavez on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Asish Xavier | 1 | 18 |
| Steve Gillis | 1 | 13 |
| Thong Le | 1 | 12 |
| Joel Marcus | 1 | 9 |
| Briggs Morrison | 1 | 8 |
| James Sullivan | 1 | 7 |
| Lindsay Rayle | 1 | 7 |
| David Schubert | 1 | 6 |
| Adam Rosenberg | 1 | 6 |
| Bruce Peacock | 1 | 5 |
| Kendall Mohler | 1 | 5 |
| Michael Heffernan | 1 | 5 |
| Ian Howes | 1 | 5 |
| Michael Poisel | 1 | 4 |
| Steven Kelly | 1 | 4 |
| Eran Nadav | 1 | 4 |
| Jonathan Behr | 1 | 4 |
| Janwillem Naesens | 1 | 3 |
| Suzanne Rettenmier | 1 | 3 |
| Chidozie Ugwumba | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.